OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

HTML PDF

Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Diabetes & Endocrinology
DOI: 10.1016/s2213-8587(22)00188-7
Authors: Nobuya Inagaki, Masakazu Takeuchi, Tomonori Oura, Takeshi Imaoka, Yutaka Seino
Institutions: Kyoto University, Eli Lilly (Japan), Kansai Electric Power (Japan), Kansai Electric Power Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: tirzepatide, dulaglutide, type 2 diabetes, GIP/GLP-1 receptor agonist, monotherapy, HbA1c, treatment-naive patients, Japanese patients, drug safety, adverse events, dose comparison, weight gain, hypoglycemia
SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, Eli Lilly Japan
OpenAlex ID: W4288740467
FWCI: 30.72
Cites: 29
Cited by: 251
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security